Arrowhead Pharmaceuticals Inc. announced that the board of directors appointed veteran pharmaceutical industry executive Victoria Vakiener, as an independent director of the company, with a term beginning effective May 2, 2022. Ms. Vakiener currently serves on the board of directors of Chimerix, a clinical-stage biopharmaceutical company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.84 USD | -2.49% | +8.07% | -15.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.56% | 3.21B | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Arrowhead Pharmaceuticals, Inc. Appoints Victoria Vakiener to Board of Directors